A safety and efficacy study of pregabalin in children 4-16 years of age for partial onset seizures

Update Il y a 4 ans
Reference: EUCTR2010-020852-79

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to evaluate the efficacy of 2 dose levels of pregabalin (Level 1: 2.5 mg/kg/day; maximum 150 mg day and Level 2: 10 mg/kg/day; maximum 600 mg day) compared to placebo as an adjunctive treatment in reducing the frequency of partial onset seizures in pediatric subjects 4 to 16 years of age.


Inclusion criteria

  • Partial onset seizures